B. Brett Finlay, Ph.D., O.C., F.R.S.C. (Chairman of Scientific Advisory Board)
Dr. Finlay is co-founder of Inimex and a highly respected researcher in the field of host-pathogen interactions, having published over 250 papers. Dr. Finlay is a professor in the Michael Smith Laboratories and in the Departments of Biochemistry & Molecular Biology and Microbiology & Immunology at the University of British Columbia.

Dr. Finlay's work was central to the development of the E.Coli 0157 vaccine and he is Director of the SARS Accelerated Vaccine Initiative and Co-Chair of the Scientific Advisory Committee of the Canadian SARS Research Consortium. He also leads an international research consortium selected by the Bill and Melinda Gates Foundation for funding under the 2005 Grand Challenges in Global Health Initiative. Dr. Finlay has received numerous prestigious awards including the E.W.R. Steacie Prize, the CSM Fisher Scientific Award, an MRC Scientist, four Howard Hughes International Research Scholar Awards, a CIHR Distinguished Investigator, the BC Biotech Innovation Award, the Michael Smith Health Research Prize and the ISDA Squibb Award. He is a Fellow of the Royal Society of Canada and the UBC Peter Wall Distinguished Professor.

Dr. Finlay received his Ph.D. from the University of Alberta and was a Postdoctoral Fellow at Stanford University School of Medicine.

R.E.W. (Bob) Hancock, Ph.D., O.C., F.R.S.C.
Bob Hancock is co-founder of Inimex, Professor of Microbiology & Immunology at UBC, and a Canada Research Chair holder. He was the founding Scientific Director of the Canadian Bacterial Diseases Network and currently heads the UBC Centre for Microbial Diseases and Immunity Research.

Dr. Hancock's research interests include antibiotic uptake and resistance, functional genomics and the development of small cationic peptides as novel antimicrobials and modulators of innate immunity. He has published more than 380 papers and reviews, being one of ISI's highly cited authors in Microbiology, and has 21 patents awarded.

Dr. Hancock has won many awards, including the Canadian Society of Microbiologists Award in 1986, Fellow of the Royal Society of Canada in 1994, the Canada 125 Silver Medal in 1995, MRC Distinguished Scientist 1995-2000, Jacob Biely Faculty Research Prize 2000, BC Biotech Alliance Innovation and Achievement Award 2001, Fellow of the American Academy of Microbiology 2002, the QEII Jubilee Medal 2002, the Aventis Pharmaceuticals Award 2003, the Zellers Scientist Award and BC Innovation Council Chairman's Award in 2004, the McLaughlin Medal of the Royal Society of Canada, 2005, the Michael Smith Prize, 2006 and the Killam Prize, 2007. In 2001 he was inducted as an Officer of the Order of Canada. Dr. Hancock has served as a Scientific Advisory Board Member or consultant with 21 biotech and pharmaceutical companies.